Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) EBT Margin (2021 - 2025)

Oncology Institute's EBT Margin history spans 5 years, with the latest figure at 5.29% for Q4 2025.

  • For Q4 2025, EBT Margin rose 786.0% year-over-year to 5.29%; the TTM value through Dec 2025 reached 12.08%, up 435.0%, while the annual FY2025 figure was 12.08%, 435.0% up from the prior year.
  • EBT Margin reached 5.29% in Q4 2025 per TOI's latest filing, up from 12.09% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 35.29% in Q1 2022 to a low of 39.31% in Q1 2023.
  • Average EBT Margin over 5 years is 11.78%, with a median of 15.0% recorded in 2025.
  • Peak YoY movement for EBT Margin: soared 3689bps in 2022, then plummeted -7460bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 24.14% in 2021, then skyrocketed by 34bps to 15.92% in 2022, then plummeted by -40bps to 22.23% in 2023, then skyrocketed by 41bps to 13.15% in 2024, then skyrocketed by 60bps to 5.29% in 2025.
  • Per Business Quant, the three most recent readings for TOI's EBT Margin are 5.29% (Q4 2025), 12.09% (Q3 2025), and 14.31% (Q2 2025).